Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry
- 1 April 2014
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 22 (6) , 762-770
Abstract
Childhood cancer survivors (CCSs) have an increased risk of overweight and dyslipidaemia, but the distribution and the potential relationships between anticancer therapies and cardiovascular risk factors have been heterogeneously and not prospectively described. All consecutive CCSs with primary cancer diagnosed between 1973-2007 and subsequently referred to our outpatient clinic were enrolled. Hypercholesterolaemia (total cholesterol >200 and/or low density lipoprotein (LDL)>160 mg/dl) was the primary end point, hypertriglyceridaemia (triglycerides >200 mg/dl) and body mass index >30 kg/m(2) the secondary end points. Cox multivariate adjustments were performed to account for differences in cancer and treatments. A total of 340 patients were included (197 male, 143 female; mean age at last follow-up 24.1 ± 3.2). The most common diagnosis were haematological malignancies (n = 227) and brain tumours (n = 51). After a median follow-up of 16.1 years, hypercholesterolaemia was diagnosed in 67 CCSs (20%), hypertriglyceridaemia in 20 CCSs (6%) and obesity in 28 CCSs (8%). Total body irradiation and growth hormone deficiency increased the risk of both hypercholesterolaemia (hazard ratio (HR) = 2.7; confidence interval (CI) 1.2-4.4 and HR = 2.3; CI 1.1-4.9; all p < 0.05) and hypertriglyceridaemia (HR = 6.5; CI 1.4-31 and HR = 7.2; CI 1.1-43; all p < 0.05). The risk of hypercholesterolaemia was also higher in CCSs who underwent autologous haematopoietic stem cell transplantation (HR = 3.2; CI 1.7-5.9; p < 0.001) or platinum-based chemotherapy (HR = 2.7; CI 1.5-4.9; p < 0.001), whereas a previous diagnosis of brain tumour (HR = 10; CI 1.2-45; p < 0.05) and anthracyclines exposure (HR = 1.3; CI 1.2-26; p < 0.05) significantly predicted obesity. CCSs show a high and variable risk for developing dyslipidaemia and obesity, depending on cancer diagnosis and treatments. Therefore, they need accurate and tailored control of their cardiovascular risk profile.Keywords
This publication has 36 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institutionJournal of Cancer Research and Clinical Oncology, 2011
- Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatmentSupportive Care in Cancer, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Psychological Distress in Adult Survivors of Childhood Cancer: The Swiss Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2010
- Hypertension in long-term survivors of childhood cancer: A nested case-control studyEuropean Journal of Cancer, 2010
- Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancerAnnals of Oncology, 2009
- Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey ReplicationJournal of Clinical Oncology, 2009
- Diabetes Mellitus in Long-term Survivors of Childhood CancerArchives of internal medicine (1960), 2009
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006